AMAG Pharmaceuticals RPE
What is the RPE of AMAG Pharmaceuticals?
The RPE of AMAG Pharmaceuticals, Inc. is $742.150k
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with rpe similar to AMAG Pharmaceuticals
- LendingTree has RPE of $740.030k
- Satin Creditcare Network has RPE of ₨740.480k
- Mediawan SA has RPE of €741.530k
- Mediawan SA has RPE of €741.530k
- Hexion has RPE of $741.795k
- Hing Lee (HK) has RPE of HKD$742.125k
- AMAG Pharmaceuticals has RPE of $742.150k
- Viasat has RPE of $742.175k
- Albertsons Companies has RPE of $742.282k
- BLS International Services has RPE of ₨742.466k
- Vertiv Co has RPE of $742.487k
- Prag Bosimi Synthetics has RPE of ₨743.089k
- China Trustful has RPE of HKD$743.235k